These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 492805)
1. Effects of methylphenidate on hyperactive children's ability to sustain attention. Charles L; Schain RJ; Zelniker T; Guthrie D Pediatrics; 1979 Oct; 64(4):412-8. PubMed ID: 492805 [TBL] [Abstract][Full Text] [Related]
2. Optimal dosages of methylphenidate for improving the learning and behavior of hyperactive children. Charles L; Schain R; Zelniker T J Dev Behav Pediatr; 1981 Sep; 2(3):78-81. PubMed ID: 7188579 [TBL] [Abstract][Full Text] [Related]
3. Behavioral and stimulant treatment of hyperactive children: a therapy study with methylphenidate probes in a within-subject design. Pelham WE; Schnedler RW; Bologna NC; Contreras JA J Appl Behav Anal; 1980; 13(2):221-36. PubMed ID: 7380749 [TBL] [Abstract][Full Text] [Related]
4. Observations on effects of a central stimulant drug (methylphenidate) in children with hyperactive behavior. Schain RJ; Reynard CL Pediatrics; 1975 May; 55(5):709-16. PubMed ID: 1093108 [TBL] [Abstract][Full Text] [Related]
6. The effects of methylphenidate on the soft neurological signs of hyperactive children. Lerer RJ; Lerer MP Pediatrics; 1976 Apr; 57(4):521-5. PubMed ID: 772581 [TBL] [Abstract][Full Text] [Related]
7. The influences of methylphenidate on heart rate and behavioral measures of attention in hyperactive children. Porges SW; Walter GF; Korb RJ; Sprague RL Child Dev; 1975 Sep; 46(3):725-33. PubMed ID: 1157610 [TBL] [Abstract][Full Text] [Related]
8. Symptoms of inattention and hyperactivity in children with habitual snoring: evidence from a community-based study in Istanbul. Arman AR; Ersu R; Save D; Karadag B; Karaman G; Karabekiroglu K; Karakoc F; Dagli E; Berkem M Child Care Health Dev; 2005 Nov; 31(6):707-17. PubMed ID: 16207229 [TBL] [Abstract][Full Text] [Related]
9. Efficacy and tolerability of OROS methylphenidate in Korean children with attention-deficit/hyperactivity disorder. Lee SI; Hong SD; Kim SY; Kim EJ; Kim JH; Kim JH; Park MK; Park S; Park JH; Oh EY; Lim TS; Cheong S; Cho IH; Choi JW Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):210-6. PubMed ID: 17046131 [TBL] [Abstract][Full Text] [Related]
10. Teacher response to the methylphenidate (ritalin) versus placebo status of hyperactive boys in the classroom. Whalen CK; Henker B; Dotemoto S Child Dev; 1981 Sep; 52(3):1005-14. PubMed ID: 7026186 [TBL] [Abstract][Full Text] [Related]
11. Efficacy of methylphenidate among mentally retarded children with attention deficit hyperactivity disorder. Handen BL; Breaux AM; Gosling A; Ploof DL; Feldman H Pediatrics; 1990 Dec; 86(6):922-30. PubMed ID: 2135682 [TBL] [Abstract][Full Text] [Related]
12. Methylphenidate in hyperkinetic children: differences in dose effects on impulsive behavior. Brown RT; Sleator EK Pediatrics; 1979 Oct; 64(4):408-11. PubMed ID: 492804 [TBL] [Abstract][Full Text] [Related]
13. The effect of methylphenidate on the cognitive and personality functioning of ADHD children. Lufi D; Parish-Plass J; Gai E Isr J Psychiatry Relat Sci; 1997; 34(3):200-9. PubMed ID: 9334525 [TBL] [Abstract][Full Text] [Related]
14. Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity. Research Units on Pediatric Psychopharmacology Autism Network Arch Gen Psychiatry; 2005 Nov; 62(11):1266-74. PubMed ID: 16275814 [TBL] [Abstract][Full Text] [Related]
15. Positive effects of methylphenidate on inattention and hyperactivity in pervasive developmental disorders: an analysis of secondary measures. Posey DJ; Aman MG; McCracken JT; Scahill L; Tierney E; Arnold LE; Vitiello B; Chuang SZ; Davies M; Ramadan Y; Witwer AN; Swiezy NB; Cronin P; Shah B; Carroll DH; Young C; Wheeler C; McDougle CJ Biol Psychiatry; 2007 Feb; 61(4):538-44. PubMed ID: 17276750 [TBL] [Abstract][Full Text] [Related]
16. Association of the adrenergic alpha2A receptor gene with methylphenidate improvement of inattentive symptoms in children and adolescents with attention-deficit/hyperactivity disorder. Polanczyk G; Zeni C; Genro JP; GuimarĂ£es AP; Roman T; Hutz MH; Rohde LA Arch Gen Psychiatry; 2007 Feb; 64(2):218-24. PubMed ID: 17283289 [TBL] [Abstract][Full Text] [Related]
17. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder. Klassen AF; Miller A; Fine S Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087 [TBL] [Abstract][Full Text] [Related]
18. Alterations in the vigilance performance of children receiving amitriptyline and methylphenidate pharmacotherapy. Kupietz SS; Balka EB Psychopharmacology (Berl); 1976 Oct; 50(1):29-33. PubMed ID: 827759 [TBL] [Abstract][Full Text] [Related]
19. Components of attention, methylphenidate dosage, and blood levels in children with attention deficit disorder. Sebrechts MM; Shaywitz SE; Shaywitz BA; Jatlow P; Anderson GM; Cohen DJ Pediatrics; 1986 Feb; 77(2):222-8. PubMed ID: 3945535 [TBL] [Abstract][Full Text] [Related]
20. Attention deficit disorder with and without hyperactivity: clinical response to three dose levels of methylphenidate. Barkley RA; DuPaul GJ; McMurray MB Pediatrics; 1991 Apr; 87(4):519-31. PubMed ID: 2011430 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]